- Home
- PXLW vs RANI Comparison
PXLW vs RANI Comparison
Compare PXLW & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- RANI
- Stock Information
- Founded
- PXLW 1997
- RANI 2012
- Country
- PXLW United States
- RANI United States
- Employees
- PXLW N/A
- RANI 140
- Industry
- PXLW Semiconductors
- RANI Medicinal Chemicals and Botanical Products
- Sector
- PXLW Technology
- RANI Health Care
- Exchange
- PXLW Nasdaq
- RANI Nasdaq
- Market Cap
- PXLW 49.1M
- RANI 55.3M
- IPO Year
- PXLW 2000
- RANI 2021
- Fundamental
- Price
- PXLW $0.81
- RANI $1.66
- Analyst Decision
- PXLW Strong Buy
- RANI Strong Buy
- Analyst Count
- PXLW 3
- RANI 6
- Target Price
- PXLW $2.17
- RANI $11.33
- AVG Volume (30 Days)
- PXLW 349.9K
- RANI 2.3M
- Earning Date
- PXLW 02-12-2025
- RANI 03-19-2025
- Dividend Yield
- PXLW N/A
- RANI N/A
- EPS Growth
- PXLW N/A
- RANI N/A
- EPS
- PXLW N/A
- RANI N/A
- Revenue
- PXLW $43,206,000.00
- RANI N/A
- Revenue This Year
- PXLW $10.25
- RANI N/A
- Revenue Next Year
- PXLW $39.19
- RANI N/A
- P/E Ratio
- PXLW N/A
- RANI N/A
- Revenue Growth
- PXLW N/A
- RANI N/A
- 52 Week Low
- PXLW $0.61
- RANI $1.24
- 52 Week High
- PXLW $3.08
- RANI $8.75
- Technical
- Relative Strength Index (RSI)
- PXLW 46.76
- RANI 54.80
- Support Level
- PXLW $0.80
- RANI $1.59
- Resistance Level
- PXLW $0.90
- RANI $1.90
- Average True Range (ATR)
- PXLW 0.06
- RANI 0.15
- MACD
- PXLW -0.01
- RANI 0.03
- Stochastic Oscillator
- PXLW 11.96
- RANI 56.36
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.